Use of albumin fusion technology to prolong the half-life of recombinant factor VIIa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of albumin fusion technology to prolong the half-life of recombinant factor VIIa

Published:2008-01 Issue: Volume:122 Page:S14-S19
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Schulte Stefan

Publisher

Elsevier BV

Subject

Hematology

Reference10 articles.

1. Mechanism of action of recombinant activated factor VII: an update;Hedner;Semin Hematol,2006

2. Pharmaceutical strategies utilizing recombinant human serum albumin;Chuang;Pharm Res,2002

3. Monomeric Fc fusions: impact on pharmacokinetic and biological activity of protein therapeutics;Dumont;BioDrugs,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Site-directed mutagenesis of tissue factor pathway inhibitor–binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity;Research and Practice in Thrombosis and Haemostasis;2024-01

2. Undiagnosed Factor VII Deficiency in Cardiac Surgery Complicated by Bleeding: A Case Report;A&A Practice;2023-09

3. Affibody-conjugated 5-fluorouracil prodrug system preferentially targets and inhibits HER2-expressing cancer cells;Biochemical and Biophysical Research Communications;2021-12

4. Serum albumin: clinical significance of drug binding and development as drug delivery vehicle;Advances in Protein Chemistry and Structural Biology;2021

5. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy;Archives of Pharmacal Research;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3